Expedient synthetic routes to [3H]-D-3-azido-3-deoxy-myo-inositol and D-3-azido-3-deoxy-myo-inositol 2,4,5-trisphosphate
Abstract
Expedient routes to a tritiated derivative of the v-sis oncogene-transformed cell specific growth inhibitor 3-azido-3-deoxy-myo-inositol and the unlabelled 2,4,5-trisphosphate derivative are described together with the effects of the latter compound in binding to the IP3 receptor.